Ceramides: Nutrient Signals that Drive Hepatosteatosis

키워드

참고문헌 (91)

1. Cahill GF Jr, "Starvation in man", Clin Endocrinol Metab, 5, pp.397~415 (1976)
2. Chaurasia B, "Targeting a ceramide double bond improves insulin resistance and hepatic steatosis", Science, 365, pp.386~392 (2019)
3. Merrill AH Jr, "De novo sphingolipid biosynthesis : a necessary, but dangerous, pathway", J Biol Chem, 277, pp.25843~25846 (2002)
4. Lone MA, "1-Deoxysphingolipids", Biochim Biophys Acta Mol Cell Biol Lipids, 1864, pp.512~521 (2019)
5. Davis D, "Orm", ORMDL proteins : gate guardians and master regulators, 2018, pp.70, 3~18
6. Cingolani F, "Ceramide synthases in biomedical research", Chem Phys Lipids, 197, pp.25~32 (2016)
7. Park JW, "Ceramide synthases as potential targets for therapeutic intervention in human diseases", Biochim Biophys Acta, 1841, pp.671~681 (2014)
8. Raichur S, "Cers2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance", Cell Metab, 20, pp.687~695 (2014)
9. Raichur S, "The role of C16 : 0 ceramide in the development of obesity and type 2 diabetes : Cers6 inhibition as a novel therapeutic approach", Mol Metab, 21, pp.36~50 (2019)
10. Turpin SM, "Obesity-induced Cers6-dependent C16 : 0 ceramide production promotes weight gain and glucose intolerance", Cell Metab, 20, pp.678~686 (2014)
11. Russo SB, "Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes", J Clin Invest, 122, pp.3919~3930 (2012)
12. Hammerschmidt P, "Cers6-derived sphingolipids interact with MFF and promote mitochondrial fragmentation in obesity", Cell, 177, pp.1536~1552 (2019)
13. Turpin-Nolan SM, "Cers1-derived C18 : 0 ceramide in skeletal muscle promotes obesity-induced insulin resistance", Cell Rep, 26, pp.1~10 (2019)
14. Sociale M, "Ceramide synthase schlank is a transcriptional regulator adapting gene expression to energy requirements", Cell Reports, 22, pp.967~978 (2018)
15. Pillai BK, "Fast diffusion of very long chain saturated fatty acids across a bilayer membrane and their rapid extraction by cyclodextrins : implications for adrenoleukodystrophy", J Biol Chem, 284, pp.33296~33304 (2009)
16. Khan MA, "Molecular mechanism for lateral lipid diffusion between the outer membrane external leaflet and a beta-barrel hydrocarbon ruler", Biochemistry, 48, pp.9745~9756 (2009)
17. Brunaldi K, "Fatty acids are rapidly delivered to and extracted from membranes by methyl-beta-cyclodextrin", J Lipid Res, 51, pp.120~131 (2010)
18. Guo W, "Fatty acid transport and metabolism in HepG2 cells", Am J Physiol Gastrointest Liver Physiol, 290, pp.G528~G534 (2006)
19. Hamilton JA, "Fatty acid transport : the diffusion mechanism in model and biological membranes", J Mol Neurosci, 16, pp.99~108 (2001)
20. Glatz JF, "Lipids and lipid binding proteins : a perfect match", Prostaglandins Leukot Essent Fatty Acids, 93, pp.45~49 (2015)
21. Jay AG, "The enigmatic membrane fatty acid transporter CD36 : new insights into fatty acid binding and their effects on uptake of oxidized LDL", Prostaglandins Leukot Essent Fatty Acids, 138, pp.64~70 (2018)
22. Xu S, "CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane", Biochemistry, 52, pp.7254~7261 (2013)
23. Xia JY, "Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis", Cell Metab, 22, pp.266~278 (2015)
24. Ehehalt R, "Uptake of long chain fatty acids is regulated by dynamic interaction of FAT", CD36 with cholesterol, BMC Cell Biol, pp.2008, 9[DOI]
25. Pohl J, "Long-chain fatty acid uptake into adipocytes depends on lipid raft function", Biochemistry, 43, pp.4179~4187 (2004)
26. Covey SD, "Cholesterol depletion inhibits fatty acid uptake without affecting CD36 or caveolin-1 distribution in adipocytes", Biochem Biophys Res Commun, 355, pp.67~71 (2007)
27. Jiang C, "Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease", J Clin Invest, 125, pp.386~402 (2015)
28. Worgall TS, "Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein", Arterioscler Thromb Vasc Biol, 24, pp.943~948 (2004)
29. Taniguchi CM, "Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda", zeta, 2006, pp.3, 343~353
30. Chen TC, "An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice", J Biol Chem, 294, pp.9213~9224 (2019)
31. Summers SA, "Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide", Mol Cell Biol, 18, pp.5457~5464 (1998)
32. Wang CN, "Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes", Diabetes, 47, pp.24~31 (1998)
33. Hyde R, "Ceramide down-regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells", FASEB J, 19, pp.461~463 (2005)
34. Finicle BT, "Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6", J Cell Sci, 131, pp.jcs213314~ (2018)
35. Guenther GG, "Ceramide starves cells to death by downregulating nutrient transporter proteins", Proc Natl Acad Sci U S A, 105, pp.17402~17407 (2008)
36. Edinger AL, "Starvation in the midst of plenty : making sense of ceramide-induced autophagy by analysing nutrient transporter expression", Biochem Soc Trans, 37, pp.253~258 (2009)
37. Cowart LA, "Yeast sphingolipids : recent developments in understanding biosynthesis, regulation, and function", Biochim Biophys Acta, 1771, pp.421~431 (2007)
38. Chung N, "Phytosphingosine as a specific inhibitor of growth and nutrient import in Saccharomyces cerevisiae", J Biol Chem, 276, pp.35614~35621 (2001)
39. Hajduch E, "Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells", Diabetologia, 44, pp.173~183 (2001)
40. Stratford S, "Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation", Biochem J, 354, pp.359~368 (2001)
41. Stratford S, "Regulation of insulin action by ceramide : dual mechanisms linking ceramide accumulation to the inhibition of Akt", protein kinase B, 2004, pp.279, 36608~36615
42. Powell DJ, "Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B(PKB)", Akt by a PKCζ-dependent mechanism, 2003, pp.23, 7794~7808
43. Chavez JA, "A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids", J Biol Chem, 278, pp.10297~10303 (2003)
44. Salinas M, "Inhibition of PKB", Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells, 2000, pp.15, 156~169
45. Teruel T, "Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state", Diabetes, 50, pp.2563~2571 (2001)
46. Zinda MJ, "Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells", Biochem Biophys Res Commun, 280, pp.1107~1115 (2001)
47. Bourbon NA, "Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ : implications for growth arrest", J Biol Chem, 277, pp.3286~3292 (2002)
48. Fox TE, "Ceramide recruits and activates protein kinase C ζ(PKCζ)within structured membrane microdomains", J Biol Chem, 282, pp.12450~12457 (2007)
49. Hajduch E, "Targeting of PKCζ and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide", Biochem J, 410, pp.369~379 (2008)
50. Dey D, "Involvement of novel PKC isoforms in FFA induced defects in insulin signaling", Mol Cell Endocrinol, 246, pp.60~64 (2006)
51. Blouin CM, "Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling", Diabetes, 59, pp.600~610 (2010)
52. Gudz TI, "Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide", J Biol Chem, 272, pp.24154~24158 (1997)
53. Di Paola M, "Ceramide interaction with the respiratory chain of heart mitochondria", Biochemistry, 39, pp.6660~6668 (2000)
54. Zigdon H, "Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain", J Biol Chem, 288, pp.4947~4956 (2013)
55. Park M, "A role for ceramides, but not sphingomyelins, as antagonists of insulin signaling and mitochondrial metabolism in C2C12 myotubes", J Biol Chem, 291, pp.23978~23988 (2016)
56. Wang X, "Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice", J Cell Biol, 184, pp.143~158 (2009)
57. Turner N, "A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism", Nat Commun, 9, pp.3165~ (2018)
58. Smith ME, "Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle", Biochem J, 456, pp.427~439 (2013)
59. Obeid LM, "Programmed cell death induced by ceramide", Science, 259, pp.1769~1771 (1993)
60. Ganesan V, "Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane", Apoptosis, 15, pp.553~562 (2010)
61. Dadsena S, "Ceramides bind VDAC2 to trigger mitochondrial apoptosis", Nat Commun, 10, pp.1832~ (2019)
62. Siskind LJ, "Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations", Mitochondrion, 6, pp.118~125 (2006)
63. Siskind LJ, "Enlargement and contracture of C2-ceramide channels", Biophys J, 85, pp.1560~1575 (2003)
64. Siskind LJ, "Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins", J Biol Chem, 277, pp.26796~26803 (2002)
65. Siskind LJ, "The lipids C2-and C16-ceramide form large stable channels. Implications for apoptosis", J Biol Chem, 275, pp.38640~38644 (2000)
66. Perera MN, "Bax and Bcl-xL exert their regulation on different sites of the ceramide channel", Biochem J, 445, pp.81~91 (2012)
67. Ganesan V, "Regulation of ceramide channels by Bcl-2 family proteins", FEBS Lett, 584, pp.2128~2134 (2010)
68. Siskind LJ, "Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels", J Biol Chem, 283, pp.6622~6630 (2008)
69. Chen Q, "Inverting the topology of a transmembrane protein by regulating the translocation of the first transmembrane helix", Mol Cell, 63, pp.567~578 (2016)
70. Chen Q, "Sustained induction of collagen synthesis by TGF-β requires regulated intramembrane proteolysis of CREB3L1", PLoS One, 9, pp.e108528~ (2014)
71. Denard B, "Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1", eLife, 1, pp.e00090~ (2012)
72. Brown MS, "Selective versus total insulin resistance : a pathogenic paradox", Cell Metab, 7, pp.95~96 (2008)
73. Park TS, "Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice", Pharmacol Res, 58, pp.45~51 (2008)
74. Glaros EN, "Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice", J Lipid Res, 49, pp.324~331 (2008)
75. Glaros EN, "Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration", Biochem Pharmacol, 73, pp.1340~1346 (2007)
76. Park TS, "Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice", Atherosclerosis, 189, pp.264~272 (2006)
77. Hojjati MR, "Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice", J Biol Chem, 280, pp.10284~10289 (2005)
78. Park TS, "Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice", Circulation, 110, pp.3465~3471 (2004)
79. Holland WL, "Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance", Cell Metab, 5, pp.167~179 (2007)
80. Dekker MJ, "Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance : evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction", Atherosclerosis, 228, pp.98~109 (2013)
81. Ussher JR, "Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption", Diabetes, 59, pp.2453~2464 (2010)
82. Yang G, "Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome", Am J Physiol Endocrinol Metab, 297, pp.E211~E224 (2009)
83. Blachnio-Zabielska AU, "Inhibition of ceramide de novo synthesis affects adipocytokine secretion and improves systemic and adipose tissue insulin sensitivity", Int J Mol Sci, 19, pp.E3995~ (2018)
84. Kurek K, "Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease", Liver Int, 34, pp.1074~1083 (2014)
85. Correnti JM, "Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice", Am J Physiol Gastrointest Liver Physiol, 306, pp.G959~G973 (2014)
86. Kasumov T, "Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis", PLoS One, 10, pp.e0126910~ (2015)
87. Chaurasia B, "Adipocyte ceramides regulate subcutaneous adipose browning, inflammation, and metabolism", Cell Metab, 24, pp.820~834 (2016)
88. Bikman BT, "Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis", J Biol Chem, 287, pp.17426~17437 (2012)
89. Shimabukuro M, "Lipoapoptosis in beta-cells of obese prediabetic fa", fa rats. Role of serine palmitoyltransferase overexpression, 1998, pp.273, 32487~32490
90. Ji R, "Increased de novo ceramide synthesis and accumulation in failing myocardium", JCI Insight, 2, pp.96203~ (2017)
91. Park TS, "Ceramide is a cardiotoxin in lipotoxic cardiomyopathy", J Lipid Res, 49, pp.2101~2112 (2008)

관련 논문AI추천